Stemcell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.
Kintor Pharma has started a Phase II trial in China for GT20029, a potential new treatment for hair loss. Participants are discussing the significance, potential release dates, and comparing it to other treatments and technologies like stemcellhairtransplants and SAMIRNA.
Stem-cellhairtransplants could potentially create thousands of grafts from a single donor graft, offering a solution for hair loss with DHT-resistant hair. Companies like Stemson Therapeutics and OrganTech are working on this technology, which may become available in the future, possibly reducing the cost and making it widely accessible.
Stemcellhairtransplants use stemcells from fat tissue to reactivate inactive hair follicles, but results are inconsistent and not widely shared. Traditional treatments like finasteride and minoxidil often show better results.
Stemcellhair restoration lacks scientific evidence and is often considered a scam. Effective hair loss treatments include hairtransplants, Minoxidil, and Finasteride, but stemcell treatments are not proven.
The user has been using finasteride for 1.5 years and minoxidil for almost 3 years for hair loss, and has seen some maintenance of hair but not significant regrowth. Suggestions from others include switching to dutasteride, trying oral minoxidil, and considering microneedling or hair fibers for better appearance.